LeonaBio, Inc. (LONA) Stock Forecast
LONA analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 4 analysts
- Price target
- $17.33 average of analyst targets
- Upside to target
- +233.3% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $-0.62
- 52-week range
- $2.87 – $11.68
LONA analyst ratings
4 analystsNumber of analysts at each rating.
LONA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
LONA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.69 | −$0.84 | −$0.53 | −$1.68 | +59.2% | 4 |
| Current fiscal year (2026) | −$2.83 | −$4.11 | −$1.96 | −$24.70 | +88.5% | 4 |
| Next fiscal year (2027) | −$2.34 | −$4.06 | −$1.15 | −$2.83 | +17.5% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
LONA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 4 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 4 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 4 |
LONA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
LONA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.71 | −$0.71 | −$0.69 | −$0.69 | −$0.69 | −3.5% | 2 up · 1 down |
| Current fiscal year (2026) | −$3.12 | −$3.12 | −$2.83 | −$2.83 | −$2.83 | −9.1% | 2 up · 1 down |
| Next fiscal year (2027) | −$1.79 | −$1.79 | −$2.34 | −$2.34 | −$2.34 | +30.7% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
LONA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; LONA beat in 8 of 12.
What analysts expect from LONA
4 analysts cover LeonaBio; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $17.33, 233.3% above the latest close of $5.20. Analysts expect earnings of −$2.83 per share for 2026, +88.5% from a year earlier. For 2027 the average estimate is −$2.34 per share. LeonaBio beat the EPS estimate in 8 of the last 12 quarters.
Related: LONA income statement, LONA key metrics, LONA chart. See the LONA stock overview for the latest quote and news.
LONA forecast FAQ
What is LeonaBio's price target?
The average analyst price target for LeonaBio is $17.33, 233.3% above the latest close of $5.20.
Is LeonaBio a buy, hold or sell?
Of 4 analysts covering LeonaBio, 2 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is LeonaBio's EPS forecast?
Analysts forecast −$2.83 per share for 2026 (range −$4.11 to −$1.96); for 2027 the estimate is −$2.34.
When does LeonaBio report earnings?
LeonaBio is expected to report results for the quarter ending September 30, 2026 on November 5, 2026; the EPS estimate is $-0.62.
Does LeonaBio usually beat earnings estimates?
LeonaBio reported EPS at or above the analyst estimate in 8 of the last 12 quarters.